Back
Corporate News
Zydus Lifesciences receives USFDA approval for Isotretinoin capsules
23-May-2025, 06:05
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) Isotretinoin capsules USP, 10 mg 20 mg, 25 mg, 30 mg, 35 mg and 40 mg (USRLD: Absorica' Capsules, 10 mg, 20 mg, 25 mg, 30 mg, 35 mg and 40 mg).
Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) Isotretinoin capsules USP, 10 mg 20 mg, 25 mg, 30 mg, 35 mg and 40 mg (USRLD: Absorica' Capsules, 10 mg, 20 mg, 25 mg, 30 mg, 35 mg and 40 mg).
Powered by Capital Market - Live News